Mylan Pharmaceuticals recalls Mylan — Amlodipine and Valsartan Tablets; Valsartan Tablets; Valsartan and Hydrochlorothiazide Tablets
- Recall date
- November 20, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Mylan Pharmaceuticals, Mylan
Why it was recalled
Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) — Unapproved Ingredient
What was recalled
Amlodipine and Valsartan Tablets; Valsartan Tablets; Valsartan and Hydrochlorothiazide Tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Mylan Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan Pharmaceuticals, Mylan